Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
03692 HANSOH PHARMA
RT Nominal up27.100 +0.600 (+2.264%)
Research Report

03/06/2025 16:01

{I-bank focus}Nomura raises Hansoh Pharma to HKD25.64

[ET Net News Agency, 3 June 2025] Nomura raised the target price for Hansoh Pharma (03692) to HKD25.64 from HKD19.86 and maintained the "neutral" r ... more View All

24/03/2025 15:34

{I-bank focus}UBS raises Hansoh Pharma (03692) to HKD24

[ET Net News Agency, 24 March 2025] UBS raised the target price for Hansoh Pharma (03692) to HKD24 from HKD22.1 and maintained the "buy" rating. Th ... more View All

23/12/2024 15:55  {I-bank focus}CMB raises Hansoh Pharma (03692) to HKD25.24

1

Remark: Real time quote last updated: 04/06/2025 12:31
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2025 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.